179 related articles for article (PubMed ID: 38644978)
21. Calcium phosphate hybrid micelles inhibit orthotopic bone metastasis from triple negative breast cancer by simultaneously killing cancer cells and reprogramming the microenvironment of bone resorption and immunosuppression.
Liu B; Yang Q; Cheng Y; Liu M; Ji Q; Zhang B; Yang Z; Zhou S; Liu D
Acta Biomater; 2023 Aug; 166():640-654. PubMed ID: 37236576
[TBL] [Abstract][Full Text] [Related]
22. Expression and localization of estrogen receptor in human breast cancer and its clinical significance.
Li L; Wang Q; Lv X; Sha L; Qin H; Wang L; Li L
Cell Biochem Biophys; 2015 Jan; 71(1):63-8. PubMed ID: 25113640
[TBL] [Abstract][Full Text] [Related]
23. Circulating interleukin-8 levels explain breast cancer osteolysis in mice and humans.
Kamalakar A; Bendre MS; Washam CL; Fowler TW; Carver A; Dilley JD; Bracey JW; Akel NS; Margulies AG; Skinner RA; Swain FL; Hogue WR; Montgomery CO; Lahiji P; Maher JJ; Leitzel KE; Ali SM; Lipton A; Nicholas RW; Gaddy D; Suva LJ
Bone; 2014 Apr; 61():176-85. PubMed ID: 24486955
[TBL] [Abstract][Full Text] [Related]
24. 15-deoxy-δ12,14-prostaglandin j2 inhibits osteolytic breast cancer bone metastasis and estrogen deficiency-induced bone loss.
Kim KR; Kim HJ; Lee SK; Ma GT; Park KK; Chung WY
PLoS One; 2015; 10(4):e0122764. PubMed ID: 25859665
[TBL] [Abstract][Full Text] [Related]
25. Estradiol induces BDNF/TrkB signaling in triple-negative breast cancer to promote brain metastases.
Contreras-Zárate MJ; Day NL; Ormond DR; Borges VF; Tobet S; Gril B; Steeg PS; Cittelly DM
Oncogene; 2019 Jun; 38(24):4685-4699. PubMed ID: 30796353
[TBL] [Abstract][Full Text] [Related]
26. The hedgehog signaling molecule Gli2 induces parathyroid hormone-related peptide expression and osteolysis in metastatic human breast cancer cells.
Sterling JA; Oyajobi BO; Grubbs B; Padalecki SS; Munoz SA; Gupta A; Story B; Zhao M; Mundy GR
Cancer Res; 2006 Aug; 66(15):7548-53. PubMed ID: 16885353
[TBL] [Abstract][Full Text] [Related]
27. Hydrogen sulphide-releasing diclofenac derivatives inhibit breast cancer-induced osteoclastogenesis in vitro and prevent osteolysis ex vivo.
Frantzias J; Logan JG; Mollat P; Sparatore A; Del Soldato P; Ralston SH; Idris AI
Br J Pharmacol; 2012 Mar; 165(6):1914-1925. PubMed ID: 21955294
[TBL] [Abstract][Full Text] [Related]
28. The essential role of YAP in ERα36-mediated proliferation and the epithelial-mesenchymal transition in MCF-7 breast cancer cells.
Park M; Lee SH; Bui QT; Kim YM; Kang KW
Front Pharmacol; 2022; 13():1057276. PubMed ID: 36534032
[No Abstract] [Full Text] [Related]
29. ERα36-GPER1 Collaboration Inhibits TLR4/NFκB-Induced Pro-Inflammatory Activity in Breast Cancer Cells.
Notas G; Panagiotopoulos A; Vamvoukaki R; Kalyvianaki K; Kiagiadaki F; Deli A; Kampa M; Castanas E
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299224
[TBL] [Abstract][Full Text] [Related]
30. Novel antitumor effect of estradiol in athymic mice injected with a T47D breast cancer cell line overexpressing protein kinase Calpha.
Chisamore MJ; Ahmed Y; Bentrem DJ; Jordan VC; Tonetti DA
Clin Cancer Res; 2001 Oct; 7(10):3156-65. PubMed ID: 11595710
[TBL] [Abstract][Full Text] [Related]
31. 14-3-3τ drives estrogen receptor loss via ERα36 induction and GATA3 inhibition in breast cancer.
Garan LAW; Xiao Y; Lin WC
Proc Natl Acad Sci U S A; 2022 Oct; 119(43):e2209211119. PubMed ID: 36252018
[TBL] [Abstract][Full Text] [Related]
32. Nitrosourea and nitrosocarbamate derivatives of the antiestrogen tamoxifen as potential estrogen receptor-mediated cytotoxic agents in human breast cancer cells.
Wei LL; Katzenellenbogen BS; Robertson DW; Simpson DM; Katzenellenbogen JA
Breast Cancer Res Treat; 1986; 7(2):77-90. PubMed ID: 3719114
[TBL] [Abstract][Full Text] [Related]
33. 17β-Estradiol inhibits testosterone-induced cell proliferation in HepG2 by modulating the relative ratios of 3 estrogen receptor isoforms to the androgen receptor.
Xu Z; Liu J; Jianxin C; Yongliang Z; Pan X
J Cell Biochem; 2018 Nov; 119(10):8659-8671. PubMed ID: 30058741
[TBL] [Abstract][Full Text] [Related]
34. Low concentrations of 17β-estradiol exacerbate tamoxifen resistance in breast cancer treatment through membrane estrogen receptor-mediated signaling pathways.
Xu Z; Zhao D; Zheng X; Huang B; Pan X; Xia X
Environ Toxicol; 2022 Mar; 37(3):514-526. PubMed ID: 34821461
[TBL] [Abstract][Full Text] [Related]
35. CIP2A is a target of bortezomib in human triple negative breast cancer cells.
Tseng LM; Liu CY; Chang KC; Chu PY; Shiau CW; Chen KF
Breast Cancer Res; 2012 Apr; 14(2):R68. PubMed ID: 22537901
[TBL] [Abstract][Full Text] [Related]
36. Sinomenine inhibits osteolysis in breast cancer by reducing IL-8/CXCR1 and c-Fos/NFATc1 signaling.
Zhang Y; Zou B; Tan Y; Su J; Wang Y; Xu J; Tao L; Zhou H; Liu L; Li X
Pharmacol Res; 2019 Apr; 142():140-150. PubMed ID: 30797069
[TBL] [Abstract][Full Text] [Related]
37. Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis.
Guise TA; Yin JJ; Taylor SD; Kumagai Y; Dallas M; Boyce BF; Yoneda T; Mundy GR
J Clin Invest; 1996 Oct; 98(7):1544-9. PubMed ID: 8833902
[TBL] [Abstract][Full Text] [Related]
38. Epidermal growth factor receptor signalling in human breast cancer cells operates parallel to estrogen receptor α signalling and results in tamoxifen insensitive proliferation.
Moerkens M; Zhang Y; Wester L; van de Water B; Meerman JH
BMC Cancer; 2014 Apr; 14():283. PubMed ID: 24758408
[TBL] [Abstract][Full Text] [Related]
39. DHA is a more potent inhibitor of breast cancer metastasis to bone and related osteolysis than EPA.
Rahman MM; Veigas JM; Williams PJ; Fernandes G
Breast Cancer Res Treat; 2013 Oct; 141(3):341-52. PubMed ID: 24062211
[TBL] [Abstract][Full Text] [Related]
40. Polyphyllin VII protects from breast cancer-induced osteolysis by suppressing osteoclastogenesis via c-Fos/NFATc1 signaling.
Yang Q; Guo J; Zheng J; Chen Y; Zou B; Li R; Ding Z; Wang Y; Li L; Chen Z; Mo L; Liang Q; Chen F; Li X
Int Immunopharmacol; 2023 Jul; 120():110316. PubMed ID: 37253315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
